Related Experiment Video
Updated: Aug 13, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Cytokine gene transfer in cancer therapy
1Department of Internal Medicine I (Hematology/Oncology), University Medical Center Freiburg, Germany.
Abstract:
New strategies based on gene transfer technology are employed in cancer therapy. Cytokines are polypeptides involved in immunity and inflammation, and essentially control the magnitude of the immune response. Genetically modified tumor cells releasing various cytokines have been shown to enhance tumor immunogenicity and to induce the regression of preexisting tumors. In some instances, immunological memory has been generated to resist the subsequent challenge with unmodified, parental tumor cells. Cytokine gene transfer into antitumor effector cells, as well as antigen presenting cells, is also being investigated to augment antitumor immune responses.
Insights
Gene transfer technology enhances cancer therapy by modifying tumor cells to release cytokines, boosting immune response and tumor regression. This approach also generates immunological memory for lasting protection against cancer.
Area of Science:
- Oncology
- Immunology
- Gene Therapy
Background:
- Cytokines are key polypeptides regulating immune responses in immunity and inflammation.
- Gene transfer technology offers novel strategies for cancer treatment.
- Genetically modified tumor cells can enhance anti-tumor immunity.
Purpose of the Study:
- To explore the use of gene transfer technology in cancer therapy.
- To investigate the role of cytokine gene transfer in enhancing anti-tumor immune responses.
- To assess the potential of modified tumor cells in inducing tumor regression and immunological memory.
Main Methods:
- Genetically modifying tumor cells to release cytokines.
- Investigating cytokine gene transfer into antitumor effector cells and antigen-presenting cells.
- Evaluating the immunogenicity and regression of tumors in response to modified cells.
Main Results:
- Genetically modified tumor cells releasing cytokines enhance tumor immunogenicity.
- Cytokine-releasing tumor cells induce regression of established tumors.
- Immunological memory is generated, providing resistance to subsequent tumor challenges.
Conclusions:
- Gene transfer of cytokines into tumor cells is a promising cancer therapy strategy.
- This approach can enhance anti-tumor immune responses and lead to tumor regression.
- The generation of immunological memory offers potential for long-term cancer protection.
Related Concept Videos
Gene Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy

